NUVBNuvation Bio Inc.
- Market cap
- $1.60B
- as of 2026-10-23
- Latest close
- $4.57
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2024-01-10
Dashed line = amended filing (Form 4/A)
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Hattersley GaryCHIEF SCIENTIFIC OFFICER | Aug 19 | Aug 21 | M | 100,000 | $1.87 | $187,000 | 100,000 | Yes | Form 4 |
| Hattersley GaryCHIEF SCIENTIFIC OFFICER | Aug 19 | Aug 21 | S | 100,000 | $7.09 | Sale −$709,000 | not reported | Yes | Form 4 |
| Hattersley GaryCHIEF SCIENTIFIC OFFICER | Aug 19 | Aug 21 | M · derivative | 100,000 | $1.87 | $187,000 | 400,000 | Yes | Form 4 |
| Sauvage PhilippeChief Financial Officer | Jul 15 | Jul 17 | M | 39,999 | $2.17 | $86,798 | 54,130 | No | Form 4 |
| Sauvage PhilippeChief Financial Officer | Jul 15 | Jul 17 | M | 1 | $1.97 | $2 | 54,131 | No | Form 4 |
| Sauvage PhilippeChief Financial Officer | Jul 15 | Jul 17 | M · derivative | 39,999 | $2.17 | $86,798 | 662,333 | No | Form 4 |
| Sauvage PhilippeChief Financial Officer | Jul 15 | Jul 17 | M · derivative | 1 | $1.97 | $2 | 499,999 | No | Form 4 |
| Wentworth KerryCHIEF REGULATORY OFFICER | Jun 23 | Jun 24 | M | 63,000 | $2.93 | $184,590 | 116,000 | Yes | Form 4 |
| Wentworth KerryCHIEF REGULATORY OFFICER | Jun 23 | Jun 24 | S | 63,000 | $6.02 | Sale −$379,260 | 53,000 | Yes | Form 4 |
| Wentworth KerryCHIEF REGULATORY OFFICER | Jun 23 | Jun 24 | M · derivative | 63,000 | $2.93 | $184,590 | 152,250 | Yes | Form 4 |
| Markel StacyCHIEF PEOPLE OFFICER | Jun 23 | Jun 24 | M | 90,380 | $1.87 | $169,011 | 122,971 | Yes | Form 4 |
| Markel StacyCHIEF PEOPLE OFFICER | Jun 23 | Jun 24 | M | 34,620 | $1.74 | $60,239 | 157,591 | Yes | Form 4 |
| Markel StacyCHIEF PEOPLE OFFICER | Jun 23 | Jun 24 | S | 125,000 | $6.03 | Sale −$753,750 | 32,591 | Yes | Form 4 |
| Markel StacyCHIEF PEOPLE OFFICER | Jun 23 | Jun 24 | M · derivative | 90,380 | $1.87 | $169,011 | 409,620 | Yes | Form 4 |
| Markel StacyCHIEF PEOPLE OFFICER | Jun 23 | Jun 24 | M · derivative | 34,620 | $1.74 | $60,239 | 220,190 | Yes | Form 4 |
| Sauvage PhilippeChief Financial Officer | Jun 23 | Jun 24 | M | 47,668 | $2.17 | $103,440 | 60,341 | Yes | Form 4 |
| Sauvage PhilippeChief Financial Officer | Jun 23 | Jun 24 | S | 47,668 | $6.01 | Sale −$286,485 | 12,673 | Yes | Form 4 |
| Sauvage PhilippeChief Financial Officer | Jun 23 | Jun 24 | M · derivative | 47,668 | $2.17 | $103,440 | 702,332 | Yes | Form 4 |
| Mashal Robert | Jun 9 | Jun 11 | P | 25,000 | $4.73 | Purchase +$118,250 | 225,000 | No | Form 4 |
| Falberg Kathryn E | May 21 | May 26 | A · derivative | 123,397 | $4.79 | $591,072 | 123,397 | No | Form 4 |
| Blickenstaff Kim D | May 21 | May 26 | A · derivative | 123,397 | $4.79 | $591,072 | 123,397 | No | Form 4 |
| Vernon W Anthony | May 21 | May 26 | A · derivative | 123,397 | $4.79 | $591,072 | 123,397 | No | Form 4 |
| Cui Xiangmin | May 21 | May 26 | A · derivative | 123,397 | $4.79 | $591,072 | 123,397 | No | Form 4 |
| Bazemore Robert B | May 21 | May 26 | A · derivative | 123,397 | $4.79 | $591,072 | 123,397 | No | Form 4 |
| Mashal Robert | May 21 | May 26 | A · derivative | 123,397 | $4.79 | $591,072 | 123,397 | No | Form 4 |
| Cui Xiangmin | Feb 27 | May 264/A | A · derivative | 76,923 | $5.91 | $454,615 | 76,923 | No | Form 4/A |
| Wentworth KerryCHIEF REGULATORY OFFICER | Apr 17 | Apr 21 | M | 36,750 | $2.93 | $107,678 | 89,750 | Yes | Form 4 |
| Wentworth KerryCHIEF REGULATORY OFFICER | Apr 17 | Apr 21 | S | 36,750 | $5.01 | Sale −$184,118 | 53,000 | Yes | Form 4 |
| Wentworth KerryCHIEF REGULATORY OFFICER | Apr 17 | Apr 21 | M · derivative | 36,750 | $2.93 | $107,678 | 215,250 | Yes | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | Apr 17 | Apr 21 | M | 50,000 | $1.94 | $97,000 | 68,000 | Yes | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | Apr 17 | Apr 21 | S | 50,000 | $5.02 | Sale −$251,000 | 18,000 | Yes | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | Apr 17 | Apr 21 | M · derivative | 50,000 | $1.94 | $97,000 | 430,000 | Yes | Form 4 |
| Wentworth KerryCHIEF REGULATORY OFFICER | Apr 6 | Apr 8 | M | 100,000 | $1.87 | $187,000 | 153,000 | Yes | Form 4 |
| Wentworth KerryCHIEF REGULATORY OFFICER | Apr 6 | Apr 8 | M | 100,000 | $1.94 | $194,000 | 253,000 | Yes | Form 4 |
| Wentworth KerryCHIEF REGULATORY OFFICER | Apr 6 | Apr 8 | S | 200,000 | $4.52 | Sale −$904,000 | 53,000 | Yes | Form 4 |
| Wentworth KerryCHIEF REGULATORY OFFICER | Apr 6 | Apr 8 | M · derivative | 100,000 | $1.87 | $187,000 | 400,000 | Yes | Form 4 |
| Wentworth KerryCHIEF REGULATORY OFFICER | Apr 6 | Apr 8 | M · derivative | 100,000 | $1.94 | $194,000 | 300,000 | Yes | Form 4 |
| Hung DavidPRESIDENT AND CEO | Feb 27 | Mar 3 | A · derivative | 1,995,012 | $5.91 | $11,790,521 | 1,995,012 | No | Form 4 |
| Wentworth KerryCHIEF REGULATORY OFFICER | Feb 27 | Mar 3 | A · derivative | 748,130 | $5.91 | $4,421,448 | 748,130 | No | Form 4 |
| Hattersley GaryCHIEF SCIENTIFIC OFFICER | Feb 27 | Mar 3 | A · derivative | 748,130 | $5.91 | $4,421,448 | 748,130 | No | Form 4 |
| Markel StacyCHIEF PEOPLE OFFICER | Feb 27 | Mar 3 | A · derivative | 748,130 | $5.91 | $4,421,448 | 748,130 | No | Form 4 |
| Hanley David C.CHIEF TECHNICAL OPERATIONS | Feb 27 | Mar 3 | A · derivative | 748,130 | $5.91 | $4,421,448 | 748,130 | No | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | Feb 27 | Mar 3 | A · derivative | 748,130 | $5.91 | $4,421,448 | 748,130 | No | Form 4 |
| Makunje MosesSEE REMARKS | Feb 27 | Mar 3 | A | 50,761 | $0.00 | $0 | 68,137 | No | Form 4 |
| Makunje MosesSEE REMARKS | Feb 27 | Mar 3 | A · derivative | 224,439 | $5.91 | $1,326,434 | 224,439 | No | Form 4 |
| Sjogren ColleenChief Commercial Officer | Feb 27 | Mar 3 | A · derivative | 748,130 | $5.91 | $4,421,448 | 748,130 | No | Form 4 |
| Sauvage PhilippeChief Financial Officer | Feb 27 | Mar 3 | A · derivative | 748,130 | $5.91 | $4,421,448 | 748,130 | No | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | Dec 1, 2025 | Dec 3, 2025 | M | 150,000 | $2.93 | $439,500 | 168,000 | No | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | Dec 1, 2025 | Dec 3, 2025 | S | 150,000 | $7.82 | Sale −$1,173,000 | 18,000 | No | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | Dec 1, 2025 | Dec 3, 2025 | M · derivative | 150,000 | $2.93 | $439,500 | 165,000 | No | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | Nov 26, 2025 | Nov 26, 2025 | M | 10,000 | $3.61 | $36,100 | 28,000 | No | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | Nov 26, 2025 | Nov 26, 2025 | S | 10,000 | $8.00 | Sale −$80,000 | 18,000 | No | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | Nov 26, 2025 | Nov 26, 2025 | M · derivative | 10,000 | $3.61 | $36,100 | 470,000 | No | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | Nov 25, 2025 | Nov 26, 2025 | M | 10,000 | $3.61 | $36,100 | 28,000 | No | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | Nov 25, 2025 | Nov 26, 2025 | S | 10,000 | $7.50 | Sale −$75,000 | 18,000 | No | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | Nov 25, 2025 | Nov 26, 2025 | M · derivative | 10,000 | $3.61 | $36,100 | 480,000 | No | Form 4 |
| Hattersley GaryCHIEF SCIENTIFIC OFFICER | Nov 20, 2025 | Nov 24, 2025 | M | 69,051 | $1.74 | $120,149 | 69,051 | No | Form 4 |
| Hattersley GaryCHIEF SCIENTIFIC OFFICER | Nov 20, 2025 | Nov 24, 2025 | S | 69,051 | $7.23 | Sale −$499,239 | not reported | No | Form 4 |
| Hattersley GaryCHIEF SCIENTIFIC OFFICER | Nov 20, 2025 | Nov 24, 2025 | M | 300,000 | $1.94 | $582,000 | 300,000 | No | Form 4 |
| Hattersley GaryCHIEF SCIENTIFIC OFFICER | Nov 20, 2025 | Nov 24, 2025 | S | 300,000 | $7.23 | Sale −$2,169,000 | not reported | No | Form 4 |
| Hattersley GaryCHIEF SCIENTIFIC OFFICER | Nov 20, 2025 | Nov 24, 2025 | M · derivative | 69,051 | $1.74 | $120,149 | 229,884 | No | Form 4 |
| Hattersley GaryCHIEF SCIENTIFIC OFFICER | Nov 20, 2025 | Nov 24, 2025 | M · derivative | 300,000 | $1.94 | $582,000 | 200,000 | No | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | Nov 20, 2025 | Nov 24, 2025 | M | 20,000 | $1.87 | $37,400 | 38,000 | No | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | Nov 20, 2025 | Nov 24, 2025 | S | 20,000 | $7.00 | Sale −$140,000 | 18,000 | No | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | Nov 20, 2025 | Nov 24, 2025 | M · derivative | 20,000 | $1.87 | $37,400 | 450,000 | No | Form 4 |
| Hanley David C.CHIEF TECHNICAL OPERATIONS | Nov 19, 2025 | Nov 21, 2025 | M | 200,000 | $1.87 | $374,000 | 224,000 | No | Form 4 |
| Hanley David C.CHIEF TECHNICAL OPERATIONS | Nov 19, 2025 | Nov 21, 2025 | S | 200,000 | $7.14 | Sale −$1,428,000 | 24,000 | No | Form 4 |
| Hanley David C.CHIEF TECHNICAL OPERATIONS | Nov 19, 2025 | Nov 21, 2025 | M · derivative | 200,000 | $1.87 | $374,000 | 300,000 | No | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | Nov 19, 2025 | Nov 19, 2025 | M | 15,000 | $1.87 | $28,050 | 30,000 | No | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | Nov 19, 2025 | Nov 19, 2025 | S | 15,000 | $5.10 | Sale −$76,500 | 18,000 | No | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | Nov 19, 2025 | Nov 19, 2025 | M · derivative | 15,000 | $1.87 | $28,050 | 470,000 | No | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | Nov 17, 2025 | Nov 19, 2025 | M | 15,000 | $1.87 | $28,050 | 30,000 | No | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | Nov 17, 2025 | Nov 19, 2025 | S | 15,000 | $4.77 | Sale −$71,550 | 15,000 | No | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | Nov 17, 2025 | Nov 19, 2025 | M · derivative | 15,000 | $1.87 | $28,050 | 485,000 | No | Form 4 |
| Hattersley GaryCHIEF SCIENTIFIC OFFICER | Oct 27, 2025 | Oct 29, 2025 | M | 100,000 | $1.74 | $174,000 | 100,000 | Yes | Form 4 |
| Hattersley GaryCHIEF SCIENTIFIC OFFICER | Oct 27, 2025 | Oct 29, 2025 | S | 100,000 | $5.02 | Sale −$502,000 | not reported | Yes | Form 4 |
| Hattersley GaryCHIEF SCIENTIFIC OFFICER | Oct 27, 2025 | Oct 29, 2025 | M · derivative | 100,000 | $1.74 | $174,000 | 298,935 | Yes | Form 4 |
| Mashal Robert | Aug 11, 2025 | Aug 13, 2025 | G · derivative | 350,001 | $1.55 | $542,502 | 391,178 | No | Form 4 |
| Mashal Robert | Aug 11, 2025 | Aug 13, 2025 | G · derivative | 350,001 | $1.55 | $542,502 | 350,001 | No | Form 4 |
| Markel StacyCHIEF PEOPLE OFFICER | Jun 18, 2025 | Jun 18, 2025 | P | 10,000 | $1.71 | Purchase +$17,100 | 29,591 | No | Form 4 |
| Sauvage PhilippeChief Financial Officer | Jun 17, 2025 | Jun 18, 2025 | P | 4,000 | $1.79 | Purchase +$7,160 | 9,902 | No | Form 4 |
| Hung DavidPRESIDENT AND CEO | Jun 16, 2025 | Jun 18, 2025 | P | 500,000 | $1.79 | Purchase +$895,000 | 59,281,054 | No | Form 4 |
| Wentworth KerryCHIEF REGULATORY OFFICER | Jun 16, 2025 | Jun 18, 2025 | P | 26,000 | $1.79 | Purchase +$46,540 | 26,000 | No | Form 4 |
| Wentworth KerryCHIEF REGULATORY OFFICER | Jun 16, 2025 | Jun 18, 2025 | P | 24,000 | $1.80 | Purchase +$43,200 | 50,000 | No | Form 4 |
| Sjogren ColleenChief Commercial Officer | Jun 16, 2025 | Jun 18, 2025 | P | 50,000 | $1.81 | Purchase +$90,500 | 81,000 | No | Form 4 |
| Sauvage PhilippeChief Financial Officer | Jun 16, 2025 | Jun 18, 2025 | P | 3,300 | $1.84 | Purchase +$6,072 | 5,902 | No | Form 4 |
| Bazemore Robert B | May 21, 2025 | May 23, 2025 | A · derivative | 292,983 | $2.03 | $594,755 | 292,983 | No | Form 4 |
| Blickenstaff Kim D | May 21, 2025 | May 23, 2025 | A · derivative | 292,983 | $2.03 | $594,755 | 292,983 | No | Form 4 |
| Falberg Kathryn E | May 21, 2025 | May 23, 2025 | A · derivative | 292,983 | $2.03 | $594,755 | 292,983 | No | Form 4 |
| Mashal Robert | May 21, 2025 | May 23, 2025 | A · derivative | 292,983 | $2.03 | $594,755 | 292,983 | No | Form 4 |
| Vernon W Anthony | May 21, 2025 | May 23, 2025 | A · derivative | 292,983 | $2.03 | $594,755 | 292,983 | No | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | May 2, 2025 | May 6, 2025 | M | 20,000 | $1.94 | $38,800 | 32,000 | Yes | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | May 2, 2025 | May 6, 2025 | S | 20,000 | $2.50 | Sale −$50,000 | 12,000 | Yes | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | May 2, 2025 | May 6, 2025 | M · derivative | 20,000 | $1.94 | $38,800 | 480,000 | Yes | Form 4 |
| Hung DavidPRESIDENT AND CEO | Apr 7, 2025 | Apr 8, 2025 | P | 300,000 | $1.63 | Purchase +$489,000 | 58,781,054 | No | Form 4 |
| Hung DavidPRESIDENT AND CEO | Apr 4, 2025 | Apr 8, 2025 | P | 200,000 | $1.66 | Purchase +$332,000 | 58,481,054 | No | Form 4 |
| Mashal Robert | Apr 1, 2025 | Apr 3, 2025 | P | 1,100 | $1.67 | Purchase +$1,837 | 101,100 | No | Form 4 |
| Mashal Robert | Apr 1, 2025 | Apr 3, 2025 | P | 98,900 | $1.67 | Purchase +$165,163 | 200,000 | No | Form 4 |
| Hanley David C.CHIEF TECHNICAL OPERATIONS | Feb 28, 2025 | Mar 4, 2025 | A · derivative | 500,000 | $1.97 | $985,000 | 500,000 | No | Form 4 |
| Hattersley GaryCHIEF SCIENTIFIC OFFICER | Feb 28, 2025 | Mar 4, 2025 | A · derivative | 500,000 | $1.97 | $985,000 | 500,000 | No | Form 4 |
| Hung DavidPRESIDENT AND CEO | Feb 28, 2025 | Mar 4, 2025 | A · derivative | 2,000,000 | $1.97 | $3,940,000 | 2,000,000 | No | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | Feb 28, 2025 | Mar 4, 2025 | A · derivative | 500,000 | $1.97 | $985,000 | 500,000 | No | Form 4 |
| Makunje MosesSEE REMARKS | Feb 28, 2025 | Mar 4, 2025 | A · derivative | 250,000 | $1.97 | $492,500 | 250,000 | No | Form 4 |
| Markel StacyCHIEF PEOPLE OFFICER | Feb 28, 2025 | Mar 4, 2025 | A · derivative | 500,000 | $1.97 | $985,000 | 500,000 | No | Form 4 |
| Sauvage PhilippeChief Financial Officer | Feb 28, 2025 | Mar 4, 2025 | A · derivative | 500,000 | $1.97 | $985,000 | 500,000 | No | Form 4 |
| Sjogren ColleenChief Commercial Officer | Feb 28, 2025 | Mar 4, 2025 | A · derivative | 500,000 | $1.97 | $985,000 | 500,000 | No | Form 4 |
| Wentworth KerryCHIEF REGULATORY OFFICER | Feb 28, 2025 | Mar 4, 2025 | A · derivative | 500,000 | $1.97 | $985,000 | 500,000 | No | Form 4 |
| Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LTD. | Nov 11, 2024 | Nov 13, 2024 | S | 56,361 | $2.89 | Sale −$162,883 | 3,866,228 | No | Form 4 |
| Mashal Robert | Oct 8, 2024 | Oct 10, 2024 | P | 19 | $2.20 | Purchase +$42 | 19 | No | Form 4 |
| Mashal Robert | Oct 8, 2024 | Oct 10, 2024 | P | 99,981 | $2.20 | Purchase +$219,958 | 100,000 | No | Form 4 |
| Sauvage PhilippeChief Financial Officer | Oct 7, 2024 | Oct 9, 2024 | A · derivative | 750,000 | $2.17 | $1,627,500 | 750,000 | No | Form 4 |
| Cui Xiangmin | Sep 4, 2024 | Sep 5, 2024 | C | 967,100 | not reported | not reported | 1,281,206 | No | Form 4 |
| Cui Xiangmin | Sep 4, 2024 | Sep 5, 2024 | C | 5,157,900 | not reported | not reported | 7,611,031 | No | Form 4 |
| Cui Xiangmin | Sep 4, 2024 | Sep 5, 2024 | C | 12,879,200 | not reported | not reported | 17,062,202 | No | Form 4 |
| Cui Xiangmin | Sep 4, 2024 | Sep 5, 2024 | C · derivative | 9,671 | not reported | not reported | not reported | No | Form 4 |
| Cui Xiangmin | Sep 4, 2024 | Sep 5, 2024 | C · derivative | 51,579 | not reported | not reported | not reported | No | Form 4 |
| Cui Xiangmin | Sep 4, 2024 | Sep 5, 2024 | C · derivative | 128,792 | not reported | not reported | not reported | No | Form 4 |
| Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LTD. | Sep 4, 2024 | Sep 5, 2024 | C | 2,543,600 | not reported | not reported | 3,922,589 | No | Form 4 |
| Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LTD. | Sep 4, 2024 | Sep 5, 2024 | C | 1,695,700 | not reported | not reported | 2,246,458 | No | Form 4 |
| Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LTD. | Sep 4, 2024 | Sep 5, 2024 | C · derivative | 25,436 | not reported | not reported | not reported | No | Form 4 |
| Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LTD. | Sep 4, 2024 | Sep 5, 2024 | C · derivative | 16,957 | not reported | not reported | not reported | No | Form 4 |
| Cui Xiangmin | Sep 3, 2024 | Sep 5, 2024 | A · derivative | 9,671 | not reported | not reported | 9,671 | No | Form 4 |
| Cui Xiangmin | Sep 3, 2024 | Sep 5, 2024 | A · derivative | 51,579 | not reported | not reported | 51,579 | No | Form 4 |
| Cui Xiangmin | Sep 3, 2024 | Sep 5, 2024 | A · derivative | 128,792 | not reported | not reported | 128,792 | No | Form 4 |
| Cui Xiangmin | Sep 3, 2024 | Sep 5, 2024 | A · derivative | 32,877 | $11.50 | $378,086 | 32,877 | No | Form 4 |
| Cui Xiangmin | Sep 3, 2024 | Sep 5, 2024 | A · derivative | 175,346 | $11.50 | $2,016,479 | 175,346 | No | Form 4 |
| Cui Xiangmin | Sep 3, 2024 | Sep 5, 2024 | A · derivative | 437,834 | $11.50 | $5,035,091 | 437,834 | No | Form 4 |
| Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LTD. | Sep 3, 2024 | Sep 5, 2024 | A · derivative | 25,436 | not reported | not reported | 25,436 | No | Form 4 |
| Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LTD. | Sep 3, 2024 | Sep 5, 2024 | A · derivative | 16,957 | not reported | not reported | 16,957 | No | Form 4 |
| Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LTD. | Sep 3, 2024 | Sep 5, 2024 | A · derivative | 86,471 | $11.50 | $994,417 | 86,471 | No | Form 4 |
| Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LTD. | Sep 3, 2024 | Sep 5, 2024 | A · derivative | 57,647 | $11.50 | $662,941 | 57,647 | No | Form 4 |
| Bazemore Robert B | Sep 3, 2024 | Sep 5, 2024 | A · derivative | 200,801 | $2.98 | $598,387 | 200,801 | No | Form 4 |
| Blickenstaff Kim D | Sep 3, 2024 | Sep 5, 2024 | A · derivative | 200,801 | $2.98 | $598,387 | 200,801 | No | Form 4 |
| Falberg Kathryn E | Sep 3, 2024 | Sep 5, 2024 | A · derivative | 200,801 | $2.98 | $598,387 | 200,801 | No | Form 4 |
| Vernon W Anthony | Sep 3, 2024 | Sep 5, 2024 | A · derivative | 200,801 | $2.98 | $598,387 | 200,801 | No | Form 4 |
| Cui Xiangmin | Jun 25, 2024 | Jun 26, 2024 | P | 277,895 | $2.97 | Purchase +$825,348 | 2,453,131 | No | Form 4 |
| Cui Xiangmin | Jun 24, 2024 | Jun 25, 2024 | P | 336,874 | $2.98 | Purchase +$1,003,885 | 2,175,236 | No | Form 4 |
| Cui Xiangmin | Jun 21, 2024 | Jun 25, 2024 | P | 75,411 | $3.00 | Purchase +$226,233 | 1,838,362 | No | Form 4 |
| Cui Xiangmin | Jun 20, 2024 | Jun 25, 2024 | P | 87,715 | $2.99 | Purchase +$262,268 | 1,762,951 | No | Form 4 |
| Blickenstaff Kim D | Jun 11, 2024 | Jun 13, 2024 | P | 172,189 | $2.90 | Purchase +$499,348 | 172,189 | No | Form 4 |
| Welch Daniel G | May 24, 2024 | May 29, 2024 | M | 293,203 | $1.74 | $510,173 | 293,203 | No | Form 4 |
| Welch Daniel G | May 24, 2024 | May 29, 2024 | M | 366,744 | $1.64 | $601,460 | 659,947 | No | Form 4 |
| Welch Daniel G | May 24, 2024 | May 29, 2024 | M · derivative | 293,203 | $1.74 | $510,173 | 19,547 | No | Form 4 |
| Welch Daniel G | May 24, 2024 | May 29, 2024 | M · derivative | 366,744 | $1.64 | $601,460 | not reported | No | Form 4 |
| Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LTD. | Apr 9, 2024 | Apr 11, 2024 | A | 1,378,989 | $0.00 | $0 | 1,378,989 | No | Form 4 |
| Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LTD. | Apr 9, 2024 | Apr 11, 2024 | A | 550,758 | $0.00 | $0 | 550,758 | No | Form 4 |
| Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LTD. | Apr 9, 2024 | Apr 11, 2024 | A · derivative | 486,669 | $0.68 | $330,935 | 486,669 | No | Form 4 |
| Wang Junyuan JerryCEO, ANHEART THERAPEUTICS LTD. | Apr 9, 2024 | Apr 11, 2024 | A · derivative | 388,299 | $0.68 | $264,043 | 388,299 | No | Form 4 |
| Sjogren ColleenChief Commercial Officer | Apr 9, 2024 | Apr 11, 2024 | A · derivative | 500,000 | $3.23 | $1,615,000 | 500,000 | No | Form 4 |
| Sjogren ColleenChief Commercial Officer | Apr 9, 2024 | Apr 11, 2024 | A · derivative | 250,000 | $3.23 | $807,500 | 250,000 | No | Form 4 |
| Cui Xiangmin | Apr 9, 2024 | Apr 11, 2024 | A | 314,106 | not reported | not reported | 314,106 | No | Form 4 |
| Cui Xiangmin | Apr 9, 2024 | Apr 11, 2024 | A | 1,675,236 | not reported | not reported | 1,675,236 | No | Form 4 |
| Cui Xiangmin | Apr 9, 2024 | Apr 11, 2024 | A | 4,183,002 | not reported | not reported | 4,183,002 | No | Form 4 |
| Hung DavidPRESIDENT AND CEO | Feb 29, 2024 | Mar 4, 2024 | A · derivative | 2,000,000 | $1.87 | $3,740,000 | 2,000,000 | No | Form 4 |
| Liu DongfangCHIEF MEDICAL OFFICER | Feb 29, 2024 | Mar 4, 2024 | A · derivative | 500,000 | $1.87 | $935,000 | 500,000 | No | Form 4 |
| Hattersley GaryCHIEF SCIENTIFIC OFFICER | Feb 29, 2024 | Mar 4, 2024 | A · derivative | 500,000 | $1.87 | $935,000 | 500,000 | No | Form 4 |
| Hanley David C.CHIEF TECHNICAL OPERATIONS | Feb 29, 2024 | Mar 4, 2024 | A · derivative | 500,000 | $1.87 | $935,000 | 500,000 | No | Form 4 |
| Makunje MosesSEE REMARKS | Feb 29, 2024 | Mar 4, 2024 | A · derivative | 250,000 | $1.87 | $467,500 | 250,000 | No | Form 4 |
| Markel StacyCHIEF PEOPLE OFFICER | Feb 29, 2024 | Mar 4, 2024 | A · derivative | 500,000 | $1.87 | $935,000 | 500,000 | No | Form 4 |
| Wentworth KerryCHIEF REGULATORY OFFICER | Feb 29, 2024 | Mar 4, 2024 | A · derivative | 500,000 | $1.87 | $935,000 | 500,000 | No | Form 4 |
| Mashal Robert | Jan 8, 2024 | Jan 10, 2024 | A · derivative | 741,179 | $1.55 | $1,148,827 | 741,179 | No | Form 4 |